ScaramuzzaA, IafuscoD, LombardoF, et al.Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events. Pediatrics, 2008; 122: 473–474, author reply 4.
2.
CopeJU, Samuels-ReidJH, MorrisonAE. Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1–12 years. J Diabetes Sci Technol, 2012; 6: 1053–1059.
3.
BarnardK, ParkinC, YoungA, et al.Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol, 2012; 6: 144–149.
4.
SchmidtS, MeldgaardM, SerifovskiN, et al.Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study. Diabetes Care, 2012; 35: 984–990.
5.
ZieglerR, CavanDA, CranstonI, et al.Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy in patients with suboptimal glycemic control. First results from the ABACUS trial. Diabetes Care, 2013; 36: 3613–3619.
6.
KowalskiA. Pathway to artificial pancreas systems revisited: moving downstream. Diabetes Care, 2015; 38: 1036–1043.
7.
RuizJL, SherrJL, CengizE, et al.Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol, 2012; 6: 1123–1130.
8.
SteilGM. Algorithms for a closed-loop artificial pancreas: the case for proportional-integral derivative control. J Diabetes Sci Technol, 2013; 7: 1621–1631.
9.
WeinzimerSA, SteilGM, SwanKL, DziuraJ, KurtzN, TamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 2008; 31: 934–939.
10.
National Telecommunications and Information Administration. A nation online: entering the broadband age. Washington, DC: U.S. Department of Commerce, 2004. Available at www.ntia.doc.gov/reports/anol/NationOnlineBroadband04.htm (Accessed June2, 2010).
11.
MitznerTL, BoronJB, FaussetCB, et al.Older adults talk technology: technology usage and attitudes. Comput Human Behav, 2010; 26: 1710–1721.
12.
MillerKM, FosterNC, BeckRW, et al.Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry. Diabetes Care, 2015; 38: 971–978.
13.
TanenbaumML, HanesSJ, MillerKM, et al.Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care, 2017; 40: 181–187.
14.
PickupJC, FordHM, SamsiK. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care, 2015; 38: 544–550.
15.
GianiE, SnelgroveR, VolkeningLK, LaffelLM. Continuous glucose monitoring (CGM) adherence in youth with type 1 diabetes: associations with biomedical and psychosocial variables. J Diabetes Sci Technol, 2017; 11: 476–483.
